Hyo Jin Kang - Concepedia

Author

Hyo Jin Kang

Also Known As

Birhanu Bayissa Gicha, H J Kang, H Kang, H. J. Kang, H. Kang, H.J. Kang, HYO JIN KANG, Hyeon Ju Kang, Hyg Jin Kang, Hyo Jin Kang

130

Publications

3.5K

Citations

H-Index

119

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center Korea Research Institute of Bioscience and Biotechnology Dankook University Dongguk University

About

Hyo Jin Kang is an author at Georgetown University specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	1.4K
2	Natural Sciences	12	12	439
3	Biochemistry	11	11	404
4	Health Sciences	6	6	442
5	Engineering	4	4	110

Hyo Jin Kang

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress Insoo Bae, Saijun Fan, Qinghui Meng, Cancer Research	2004	221
Exercise and Genetic Rescue of SCA1 via the Transcriptional Repressor Capicua John Denis Fryer, Peng Yu, Hyo Jin Kang, Science GeneticsGenetic RescueMolecular GeneticsTranscriptional Repressor CapicuaMild Exercise Regimen	2011	167
A highly selective fluorescent ESIPT probe for the dual specificity phosphatase MKP-6 Tae‐Il Kim, Hyo Jin Kang, Garam Han, Chemical Communications	2009	152
Structure of human α-enolase (hENO1), a multifunctional glycolytic enzyme Hyo Jin Kang, Suk‐Kyeong Jung, Seung Jun Kim, Acta Crystallographica Section D Biological Crystallography	2008	113
Controlled antibody immobilization onto immunoanalytical platforms by synthetic peptide Yongwon Jung, Hyo Jin Kang, Jeong Min Lee, Analytical Biochemistry Peptide EngineeringImmunologyAntibody EngineeringMedicineAntibody Immobilization	2007	98
Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells Yong Weon Yi, Hyo Jin Kang, Hee Jeong Kim, Oncotarget Mutant P53Tumor BiologySirt1 Activator Yk-3-237Breast OncologyOncology	2013	92
Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells Young Bin Hong, Hyo Jin Kang, Sun Young Kwon, Pancreas	2010	88
Acetylation of malate dehydrogenase 1 promotes adipogenic differentiation via activating its enzymatic activity Eun Young Kim, Won Kon Kim, Hyo Jin Kang, Journal of Lipid Research BiosynthesisEnergy MetabolismHealth SciencesBiochemistryMalate Dehydrogenase 1	2012	84
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells Hong‐Quan Duong, Jae Seok Hwang, Hee Jeong Kim, International Journal of Oncology Gem ResistanceAldehyde Dehydrogenase 1A1Tumor BiologyOxidative StressDrug Resistance	2012	77
Inhibition of the <scp>PI</scp>3K/<scp>AKT</scp> pathway potentiates cytotoxicity of <scp>EGFR</scp> kinase inhibitors in triple‐negative breast cancer cells Yong Weon Yi, Wooyoung Hong, Hyo Jin Kang, Journal of Cellular and Molecular Medicine	2013	77

Page 1